Inspired by the African response to the Covid-19 pandemic, the 2023 Partnerships for Prevention and Care Africa Health Conference will focus on building Africa’s national health care response resources to increase prevention of infectious diseases through private public partnerships.
www.corporateafricahealthfoundation.org

Corporate Africa Partnerships for Prevention and Care Africa Health Conference will take place under the auspices of the Health Ministry of Kenya. Corporate Africa is seeking abstracts for the event planned to be held during July 2nd – 4th, 2023 at Nairobi, Kenya and virtually. The theme of the conference is “Private Public Partnerships building capacity in African Health and Medicare:”

Partnership Opportunities
Collaborations and partnerships to bring together medical professions who are adept at issuing life saving technology and skills; also, governments and patients associations which have knowledge about the burden of diseases and national capabilities, and the private sector with its huge resources encompassing financial capacity, connective technologies, know how, and global influence. PPPs combined resources work to combat the spread of diseases including, Malaria, TB, HIV, Diabetes, cancer and Covid-19, through better diagnosis, technology and increased capacity.

Safari Park Hotel, Nairobi, Kenya
Persons and organizations wishing to submit abstracts for oral and poster presentations at the conference are invited to tender their submissions to the Event Coordinator. As a requirement for acceptance, abstracts should cover proposed thematic areas under “Conference Theme” and set out how they meet the requirements of the event and general interest of participants. It should also describe the contents of the presentation, addressing specific issues and clearly explaining the impact in health and Medicare

Key Issues
Key issues relates to the prevention and care of diseases in countries with weakened health and Medicare infrastructure systems re HIV, Covid-19, Malaria, TB, Cancer and Diabetes. It also addresses national and regional responses that provide solutions to challenges; and how they could be strengthened and made sustainable by collaborating and partnering with local and international investors and life science companies.